Browse Related Topics For:

Generic Drugs

418
Pharmaceutical Industry
250
Patents
234
Prescription Drugs
229
Pharmaceutical Patents
191
Patent Infringement
189
FDA
182
ANDA
171
Patent Litigation
135
Hatch-Waxman
80
SCOTUS
76
FTC
61
Reverse Payment Settlement Agreements
60
FTC v Actavis
56
Pay-For-Delay
53
Actavis Inc.
52
Biosimilars
48
Preemption
38
Antitrust Litigation
37
Manufacturers
36
Teva Pharmaceuticals
33
Popular
32
Mylan Pharmaceuticals
29
Labeling
27
BPCIA
27
FDA Approval
27
Sandoz
26
FDCA
26
Healthcare
24
Apotex
24
Failure To Warn
24
Medical Devices
22
AstraZeneca
22
Inter Partes Review Proceedings
21
Appeals
21
Prior Art
20
Watson Pharmaceuticals
19
Amgen
19
Design Defects
19
Novartis
18
Biotechnology
18
Merck
18
Warning Labels
17
DOJ
17
Patent Trial and Appeal Board
17
Sherman Act
16
Biologics
16
Infringement
16
Medicare
16
Mutual Pharmaceuticals v Bartlett
16
Preliminary Injunctions
16
Settlement
16
USPTO
15
Drug Pricing
15
Medicaid
15
Patent-in-Suit
15
PLIVA v Mensing
14
Affordable Care Act
14
Commercial Marketing
14
Innovator Liability
14
Orange Book
14
Patent Applications
14
Sandoz v Amgen
13
Declaratory Judgments
13
Eli Lilly
13
EU
13
Obviousness
13
Patent Invalidity
13
Product Hopping
12
America Invents Act
12
Anti-Competitive
12
Antitrust Provisions
12
Bayer
12
Class Action
12
Personal Jurisdiction
12
Pharmacies
11
CA Supreme Court
11
Cephalon
11
Corporate Counsel
11
Hospira
11
Patent Dance
10
Jurisdiction
10
Notice Requirements
10
Otsuka Pharmaceutical
10
Rule-of-Reason Analysis
10
Safe Harbors
9
China
9
CMS
9
Hedge Funds
9
HHS
9
OIG
9
On-Sale Bar
9
Pfizer
9
Trademarks
8
Allergan Inc
8
Gilead Sciences
8
GlaxoSmithKline
8
Hospitals
8
Life Sciences
8
Orphan Drugs
8
Proposed Legislation
8
Reverse Payments
8
Wyeth
7
Endo Pharmaceuticals
7
Health Care Providers
7
Noninfringement
7
Product Labels
7
RanBaxy
7
Summary Judgment
7
Warner Chilcott
6
Abuse of Process
6
Antitrust Investigations
6
Antitrust Violations
6
Claim Construction
6
Competition
6
Draft Guidance
6
Enforcement Actions
6
False Claims Act (FCA)
6
Federal Budget
6
Government Investigations
6
Intellectual Property Protection
6
Janssen Pharmaceuticals
6
Jazz Pharmaceuticals
6
Misrepresentation
6
Nexium
6
No-AG Agreement
6
Par Pharmaceutical
6
Post-Grant Review
6
Rebates
6
Suppliers
5
AbbVie
5
Biologics Price Competition and Innovation Act of 2009
5
Cipro
5
Comment Period
5
Compliance
5
Congressional Investigations & Hearings
5
Dismissals
5
Drug Safety
5
Exclusivity
5
Exports
5
Intellectual Property Litigation
5
Martin Shkreli
5
Medicare Part B
5
Monopolization
5
Motion to Dismiss
5
New Legislation
5
Off-Label Promotion
5
Patent-Eligible Subject Matter
5
Product Exclusivity
5
Professional Conferences
5
Proposed Regulation
5
Putative Class Actions
5
Standing
5
Takeda Pharmaceuticals
4
aBLA
4
Anticompetitive Agreements
4
Attorney Generals
4
Australia
4
Boehringer
4
Brand
4
Canada
4
Cancer
4
Cartels
4
Cartwright Act
4
Classen Immunotherapies
4
DaimlerAG
4
Doctrine of Equivalents
4
Duty to Deal
4
European Commission
4
Federal Rule 12(b)(6)
4
First Amendment
4
Forum Shopping
4
Induced Infringement
4
Innovation
4
Johnson & Johnson
4
Kickbacks
4
Marketing
4
Medicare Part D
4
Mensing
4
Mental Health
4
OPPS
4
Pleading Standards
4
Product Defects
4
Real Party in Interest
4
Research and Development
4
Roxane Laboratories
4
Section 340B
4
Settlement Agreements
4
Spectrum
4
Subpoenas
4
UK
3
Abbott Laboratories
3
Amarin
3
Anti-Kickback Statute
3
Antitrust Conspiracies
3
Antitrust Division
3
Causation
3
Civil Monetary Penalty
3
Clinical Trials
3
Congressional Committees
3
DaimlerChrysler v Bauman
3
De Novo Standard of Review
3
Debt Ceiling
3
Disgorgement
3
Estoppel
3
False Advertising
3
First Sale Doctrine
3
Forest Laboratories
3
GDUFA
3
General Jurisdiction
3
Generic
3
Google
3
Health Insurance
3
Healthcare Reform
3
Hoffman LaRoche
3
Injunctions
3
Innovation Act
3
Legislative Agendas
3
Licensing Rules
3
Manufacturing Defects
3
Medicare Modernization Act
3
Mergers
3
Minimum Contacts
3
Motion for Sanctions
3
Obama Administration
3
Off-Label Use
3
Patent Term Adjustment
3
Pending Legislation
3
Permanent Injunctions
3
Physician Fee Schedule
3
Public Health Service Act
3
REMS
3
Reversal
3
Rulemaking Process
3
Sequestration
3
SmithKline Beecham
3
Specific Jurisdiction
3
Telehealth
3
Third-Party Relationships
3
Unfair Competition
3
Whistleblowers
3
Wholesale
2
21st Century Cures Initiative
2
Abuse of Dominance
2
Acquisitions
2
Allergan v Sandoz
2
Ambulatory Surgery Centers
2
Antitrust Injuries
2
Automatic Enrollment
2
Barack Obama
2
Biogen Idec
2
Biopharmaceutical
2
Breach of Warranty
2
Burden of Proof
2
Cadillac Tax
2
CAFC
2
CDC
2
Chevron Deference
2
Citizen Petitions
2
Co-Op
2
Competition Authorities
2
Consent Order
2
Contraceptive Coverage Mandate
2
Copyright
2
Covered Business Method Patents
2
Data Protection
2
Direct Purchasers
2
Disclosure
2
Discovery
2
Drug Approvals
2
Drug Compounding
2
Durable Medical Equipment
2
E-Cigarettes
2
Elan Pharmaceuticals
2
En Banc Review
2
Expert Testimony
2
Failure To State A Claim
2
Federal Aviation Administration (FAA)
2
Federal Question Jurisdiction
2
Food Safety
2
Foreign Manufacturers
2
Fraud
2
Free Speech
2
Fresenius
2
FTC Act
2
Genentech
2
Health Information Technologies
2
Healthcare Costs
2
Imports
2
India
2
Interlocutory Injunctions
2
International Harmonization
2
INTERPOL
2
Inventions
2
Inventors
2
IP License
2
Japan
2
John Boehner
2
Joinder
2
Lanham Act
2
Learned Intermediary
2
License Agreements
2
Licenses
2
Medical Research
2
MedPAC
2
Medtronic
2
Motion for Reconsideration
2
Motion To Stay
2
Multidistrict Litigation
2
Multinationals
2
Native American Issues
2
Negligence
2
New Guidance
2
NIH
2
Non-Compete Agreements
2
Nursing Homes
2
Octane Fitness v. ICON
2
Offsets
2
Opioid
2
Out-of-State Companies
2
OxyContin
2
PATENT Act
2
Patent Owner Preliminary Response
2
Patent Reform
2
Patent Term Extensions
2
Patients
2
PHRMA
2
Physician Medicare Reimbursements
2
Physicians
2
Prescription Drug Coverage
2
Presumption of Validity
2
Price-Fixing
2
Prilosec
2
Private Right of Action
2
Public Disclosure
2
Public Health
2
Qui Tam
2
Recordkeeping Requirements
2
Retailers
2
SEC
2
Settlements
2
Shire Development v Watson
2
Software
2
State Law Tort Claims
2
Strategic Enforcement Plan
2
STRONG Patents Act
2
Subject Matter Jurisdiction
2
Substance Abuse
2
Supplementary Protection Certificate
2
Telemedicine
2
Teva v Sandoz
2
The Clayton Act
2
Trademark Registration
2
Trans-Pacific Partnership
2
Transfer of Venue
2
TRIPS Agreement
2
TRO
2
Twombly/Iqbal Pleading Standard
2
UK Competition and Markets Authority (CMA)
2
Unjust Enrichment
2
Websites
1
35 U.S.C. § 271(e)(1)
1
3D Printing
1
510(k) RTA
1
Acceleration
1
ACOs
1
Actos
1
Advance Notice
1
Advertising
1
Aircraft
1
AL Supreme Court
1
Alien Tort Statute
1
Alternative Payment Models (APM)
1
Ambiguous
1
Amended Complaints
1
Amended Regulation
1
Amnesty
1
AMP v Myriad
1
Anti-Corruption
1
Antibiotics
1
Anticompetitive Behavior
1
App Developers
1
Apple
1
Arbitration
1
Asia Pacific
1
Assignments
1
Australian Competition and Consumer Commission
1
Auto Manufacturers
1
Auto Parts
1
Automatic Stay
1
Automotive Industry
1
Aviation Industry
1
Bad Debt
1
Banking Sector
1
Barclays
1
Bausch & Lomb
1
Best Practices
1
Bifurcation
1
Bipartisan Budget
1
Bipolar Disorder
1
Birth Defects
1
Boeing
1
Books
1
Bowman v Monsanto
1
Boycotts
1
BPCI
1
Brazil
1
Bribery
1
Bristol-Myers Squibb
1
Bundled Payments
1
Burden-Shifting
1
Cadence Pharmaceuticals Inc.
1
CAFA
1
Carve Out Provisions
1
Cease and Desist Orders
1
Center for Drug Evaluation and Research (CDER)
1
CFDA
1
Charitable Organizations
1
Charitable PAPs
1
Cisco v CommilUSA
1
Class Certification
1
Class Members
1
Classification
1
Clear and Convincing Evidence
1
Clearance
1
Color Marks
1
Community Trademark
1
Compensation
1
Competition Act
1
Complex Litigation
1
Confidentiality Agreements
1
Conflicting Proposals
1
Consumer Fraud
1
Consumer Product Safety Commission (CPSC)
1
Contingency Fees
1
Contraceptives
1
Copyright Infringement
1
Copyright Litigation
1
Corrective Actions
1
Corruption
1
Cost-Sharing
1
Counterclaims
1
Counterfeit Drugs
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Proceedings
1
Criminal Antitrust Litigation
1
Customer-Loyalty Programs
1
CVS
1
Daiichi Sankyo
1
Dairy Farmers
1
Damages
1
Data Breach
1
Data Collection
1
DE Supreme Court
1
Defect
1
Deficit Reduction
1
Delaware General Corporation Law
1
Department of Veterans Affairs
1
Design Patent
1
Designer Professionals' Liability
1
Device Classification
1
DHS
1
Diagnostic Tests
1
Dietary Supplements
1
Direct Infringement
1
Directed Verdicts
1
Disclosure Requirements
1
Discovery Rule
1
Dismissal With Prejudice
1
Disparagement
1
Dispute Resolution
1
Distributors
1
Diversity Jurisdiction
1
Divestiture
1
Divided Infringement
1
Divisional Applications
1
DOHA
1
DOL
1
DQSA
1
Drug Distribution
1
DSCSA
1
Duty of Care
1
Duty to Warn
1
EAR
1
Edith Ramirez
1
EHR
1
Elder Issues
1
Email
1
Emerging Markets
1
Employer Mandates
1
Energy Sector
1
Enforcement
1
Entertainment Industry
1
EPA
1
European Patent Office
1
Evidence Suppression
1
Exceptional Case
1
Exceptions
1
Exclusive Licenses
1
Extraterritoriality Rules
1
Facebook
1
FCPA
1
FDA Warning Letters
1
FDASIA
1
Federal Jurisdiction
1
Federal Register
1
Federal Rule 12(b)(1)
1
Federal Rules of Civil Procedure
1
Federal Trade Commission Act
1
Fee-for-Service
1
Filing Fees
1
Final Rules
1
Financial Instruments
1
Fines
1
Food Contamination
1
Food Labeling
1
Food Recalls
1
Foreign Corporations
1
Foreign Exchanges
1
Foreign Investment
1
Foreign Trade Regulations
1
Foreseeability
1
Form 8-K
1
Forum
1
Forum Non Conveniens
1
Forum Selection
1
France
1
FRAND
1
Fraud and Abuse
1
Fraudulent Concealment
1
Fraudulent Inducement
1
Fraudulent Procurement
1
French Competition Authority
1
FTEs
1
Genetically Engineered Seed
1
Genzyme
1
Germany
1
Goodyear
1
Governor Brown
1
Governor Cuomo
1
Grable Factors
1
Grand Juries
1
Grocery Stores
1
Hart-Scott-Rodino Act
1
Hazardous Waste
1
Health Safety
1
Healthcare Facilities
1
HEAT
1
HELP
1
Hepatitis C
1
Highmark
1
Highmark v. Allcare
1
Home Health Care
1
Honeywell International
1
Hospital Mergers
1
Hotels
1
HRSA
1
Human Genes
1
ICD-10
1
Imminent Harm
1
Implied Preemption
1
Indirect Purchasers
1
Inflation Adjustments
1
Information Disclosure Statement
1
Information Reports
1
Informed Consent
1
Injunctive Relief
1
Inspections
1
Inspector General
1
Insurance Industry
1
Intent-to-Use
1
Interest Rates
1
International Arbitration
1
International Treaties
1
Investors
1
IPR
1
IRF Claim Processing
1
Irreparable Harm
1
IRS
1
Italy
1
ITC
1
Joint Venture
1
Judges
1
Jury Awards
1
Jury Verdicts
1
Justiciable Controversy
1
King v Burwell
1
Kirtsaeng v. John Wiley & Sons
1
Kmart
1
Laches
1
Leave to Amend
1
LG Electronics
1
Libor
1
Likelihood of Success
1
Limelight v Akamai
1
Lipitor
1
Long Term Care Facilities
1
Loss Causation
1
MACs
1
Material Defects
1
Media
1
Medical Foods
1
Medicare Advantage
1
Member State
1
Method Claims
1
Microsoft
1
Ministry of Health
1
Mistrial
1
Monsanto
1
Mootness
1
Motion To Centralize
1
Motorola
1
Myriad
1
Negligent Design
1
Negotiations
1
New Regulations
1
New Trial
1
Nexus
1
Nike
1
NJ Supreme Court
1
Non-Grandfathered Health Plans
1
Notice of Intent
1
Notifications
1
Nutritional Supplements
1
Office Depot
1
Omnicare
1
Online Drug Sales
1
Open Enrollment
1
OTDP
1
Out-of-State Judgments
1
PACE
1
Pain Management Clinics
1
Parallel Claims
1
Patent Assertion Entities
1
Patent Exhaustion
1
Patent Filings
1
Patent Prosecution
1
Patent Trolls
1
Patent Validity
1
Patent-Misuse
1
Patentability Search
1
Patient Assistance Programs
1
Patient Self-Referral
1
Pay-to-Delay System
1
Petition for Writ of Certiorari
1
Pharmaceutical Benefits Scheme
1
Pharmaceutical Distribution
1
Pharmaceutical Reverse Distributors
1
Pharmacist
1
Physician Payments
1
Premarket Approval Applications
1
Presidential Elections
1
Pretext
1
Price Manipulation
1
Price Transparency
1
Proctor & Gamble
1
Profits
1
Prometheus
1
Proposed Amendments
1
Public Meetings
1
Public Performance Rights
1
Public Procurement Policies
1
Public Transportation
1
Public Use
1
Rare Earth Metals
1
Registration
1
Registration Requirement
1
Regulatory Agenda
1
Regulatory Standards
1
Reimbursements
1
Reissue Patents
1
Relators
1
Renewal Fees
1
Reporting Requirements
1
Res Ipsa Loquitur
1
Restraining Orders
1
Restraint of Trade
1
RICO
1
Risk Assessment
1
Risk Management
1
Risk Mitigation
1
ROI
1
Rule 11
1
Rural Areas
1
Rural Health Care Program
1
Safety Precautions
1
Sales Contracts
1
SAMHSA
1
Samsung
1
Sanofi-Aventis
1
Schering-Plough
1
Section 2
1
Senate Judiciary Committee
1
SFDA
1
Sham Citizen Petitions
1
Sham Litigation Exception
1
Shell Oil
1
Skilled Nursing Facility
1
SNDAs
1
Social Security
1
Spoliation
1
Sponsors
1
Sports
1
Standard Essential Patents
1
Standard of Proof
1
Standard of Review
1
Standing Objections
1
Staples
1
State Health Insurance Exchanges
1
Stem cells
1
Stocks
1
Structured Financial Products
1
Supply Chain
1
Surveys
1
Tariffs
1
Tax Credits
1
Teamsters
1
Textbooks
1
Textiles
1
TFEU
1
Tobacco Regulations
1
Tolling
1
Tortious Interference
1
Trade Agreements
1
Trade Promotion Authority
1
Trade Relations
1
Trade Secrets
1
Trademark Application
1
Trademark Searches
1
Transfer of Title
1
Transparency
1
Transvaginal Mesh
1
Two-Midnight Rule
1
U.S. Treasury
1
Unfair Pricing
1
Uniform Commercial Code (UCC)
1
Unitary Patent
1
Universal Health Services Inc v United States ex rel Escobar
1
Vacated
1
Vaccinations
1
Valeant
1
Veterans
1
Veterinary Products
1
Viagra
1
Walker Process Claims
1
Warranties
1
Webinars
1
White Collar Crimes
1
WIPO
1
Wireless Devices
1
Women's Preventable Healthcare Mandates
1
Work Plans
1
World Intellectual Property Organisation
1
Wrongful Death
1
WTO
1
Young Lawyers